Previsão

Comprar	1
Manter	0
Vender	0

Notícias Ir para o feed de notícias

BIOkey beats profit target, misses revenue forecast and stock falls sharply

BIOkey reported an adjusted loss of $0.56 per share for Q2/2026, beating expectations, while revenue of $1.92 million missed the consensus of $2.2 million. Gross margins and licensing income rose significantly, and net loss narrowed 51% year over year, but a delayed large order and a warrant financing weighed on the market reaction. The stock fell about 12%; management expects profitability in H2/2026 and sees growth potential in Passkey:YOU, PortalGuard 7.0 and in EMEA/Middle East. » Mais em de.investing.com
BIO key increases revenue by 13%; net loss halved

BIO key reported Q2 revenue of USD 1.9 million (up 13%) and a halved net loss of USD 577,000. License revenues rose 53% to USD 1.2 million, while hardware sales fell 19%; expected hardware sales of about USD 800,000 were pushed into H2 2026. Gross margin improved to 87%; cash balance increased to over USD 4.5 million following the exercise of warrants. The company announced several customer contracts (including Saudi Arabia, Portugal, Jordan) and completed a 1:10 reverse stock split, restoring NASDAQ listing requirements. » Mais em de.investing.com
BIO-key receives reprimand from Nasdaq over late 10-Q filing

BIO-key received a reprimand from Nasdaq for noncompliance with Rule 5250(c)(1) after the quarterly report (Form 10-Q) for the period ended March 31, 2026 was not filed with the SEC on time. The Nasdaq Hearing Panel will take the violation into account when deciding on the company’s continued listing on the Nasdaq Capital Market. The stock has fallen 41% over the past six months and is currently trading at $4.10 with a market capitalization of about $4.45 million; InvestingPro rates the financial position as “WEAK” with a score of 1.67, but sees possible undervaluation. » Mais em de.investing.com

Dados financeiros da empresa

No último trimestre, BIO-Key International registou receitas de € 1,68 mi e um ganho líquido de -€ 505,44 mil

(EUR)	junho de 2026	YoY
Receitas	1,68 mi	16,85%
Ganho bruto	1,47 mi	40,25%
Ganho líquido	-505,44 mil	48,97%
EBITDA	-445,62 mil	49,56%

Dados fundamentais

Métrica	Valor
Capitalização bolsista	€ 2,49 mi
Número de ações	1,09 mi
Máximo/mínimo de 52 semanas	€ 17,07 - € 2,23
Dividendos	Não
Beta	0,40
PER (PE Ratio)	-0,65
PEG (PEG Ratio)	0,00
P/VC (PB Ratio)	0,63
P/V (PS Ratio)	0,42

Perfil da empresa

BIO-key International, Inc. entwickelt und vermarktet biometrische Technologien und Softwarelösungen zur Identifizierung von Fingerabdrücken sowie unternehmenstaugliche Lösungen für das Identitäts- und Zugangsmanagement für Unternehmen, Behörden und Bildungseinrichtungen in den Vereinigten Staaten und international. Das Unternehmen bietet die Lösungen BIO-key PortalGuard und PortalGuard IDaaS an, eine vom Kunden kontrollierte und designneutrale Cloud-basierte Identitätsplattform, die Kunden die Integration mit jeder Cloud- oder lokalen SaaS-Anwendung sowie die Authentifizierung von Windows-Geräten über die IAM-Plattform ermöglicht. Die Lösungen des Unternehmens ermöglichen es seinen Kunden, ihre Mitarbeiter und Studenten zu schützen und die Zusammenarbeit in ihren Partnernetzwerken zu verbessern. Darüber hinaus bietet das Unternehmen BIO-key VST- und WEB-key-Produkte sowie zivile und groß angelegte ID-Infrastrukturlösungen, die biometrische Technologie auf Fingerbasis entwickeln. Darüber hinaus bietet es unter den Markennamen SideSwipe, EcoID und SidePass Fingerscanner für den Unternehmens- und Verbrauchermarkt an. Das Unternehmen war früher unter dem Namen SAC Technologies bekannt und änderte 2002 seinen Namen in BIO-key International, Inc. BIO-key International, Inc. wurde 1993 gegründet und hat seinen Hauptsitz in Wall, New Jersey.